Wolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc.

Core Viewpoint - Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential breaches of fiduciary duty by the Board of Directors and senior management of Semler Scientific Inc. related to securities fraud allegations [1][2]. Investigation Details - The investigation focuses on whether certain officers and/or directors of Semler have engaged in securities fraud [2]. - Semler disclosed in its Form 10-K filed on February 28, 2025, that it received a civil investigative demand from the U.S. Department of Justice (DOJ) in July 2017 regarding claims for reimbursement related to the QuantaFlo device [3]. - Subsequent requests for information from the DOJ occurred in February 2019, December 2021, April 2022, and April 2023, with unsuccessful settlement discussions taking place in February 2025 [3]. - There is a risk that the DOJ may file a complaint in a civil False Claims Act lawsuit seeking damages against Semler [3]. Firm Background - Wolf Haldenstein has extensive experience in prosecuting securities class actions and derivative litigation across state and federal courts [3]. - The firm is recognized for its expertise in shareholder and class litigation, having been appointed to significant positions in complex securities and multi-district litigation by the courts [3].